IRF7 blocking peptide product blog
Tags: IRF7; Blocking Peptide; IRF7 blocking peptide;
The IRF7 irf7 (Catalog #MBS153189) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s IRF7 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).IRF7 peptide is used for blocking activity of IRF7 antibody. Researchers should empirically determine the suitability of the IRF7 irf7 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The IRF7 irf7 product has the following accession number(s) (GI #116242593) (NCBI Accession #Q92985.2) (Uniprot Accession #Q92985). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Species: Human
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 14 amino acids near the carboxy terminus of human IRF7. Blood, Bone, Bone Marrow, Brain, Intestine, Kidney, Liver, Lung, Skin, Spleen tissues are correlated with this protein. IRF7 also interacts with the following gene(s): IFIT2, IFIT3, IRAK1, ISG15, MX1, MYD88, OAS2, TBK1, TRAF6. Adenocarcinoma, Cardiovascular Diseases, Disease Models, Animal, Inflammation, Influenza, Human, Kidney Diseases, Liver Diseases, Liver Neoplasms, Necrosis, Neoplasms, Experimental are some of the diseases may be linked to IRF7 Peptide. The following patways have been known to be associated with this gene.